Puma Biotechnology | Despesa De Juros Sobre A Dívida



Interest Expense On Debt Alterar Data
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 38.65M 325K 2025-03
Amgen USD 723M 24M 2025-03
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.86M 286K 2025-03
Daiichi Sankyo 7.08B 4.54B 2025-03
Exelixis 23.4M 3.9M 2023-09
Gilead Sciences USD 260M 12M 2025-03
Glaxosmithkline 178.05M 24.73M 2024-12
Incyte USD 660K 241K 2025-03
MacroGenics USD -24000 24K 2024-12
Moderna USD 1000K 5M 2025-03
Novartis USD 275M 11M 2024-12
Pfizer USD 654M 85M 2025-03
PTC Therapeutics USD 43.35M 1.24M 2024-12
Regeneron Pharmaceuticals USD 8.7M 1.8M 2025-03
Roche Holding CHF 311.5M 1000K 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
Takeda 50.32B 18.73B 2025-03
TG Therapeutics USD 10.83M 6.86M 2024-09
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



Puma Biotechnology Despesa De Juros Sobre A Dívida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.